Carmen Tarleton's body very nearly rejected a face transplantation, and she chose to take the powerful anti-rejection drug alemtuzumab, which could have completely shut down her immune system, rather than have doctors remove the new face. A small dose of the drug was enough to stop the rejection, giving surgeons new information on how to counter organ rejection.

Full Story:
Al Jazeera

Related Summaries